Life Science Compliance Update

October

2016

Helping the Patient – Co-Pay Reimbursement Can Be Okay in Certain Circumstances

Written by , Posted in Abstract, Compliance Operations

Robert N. Wilkey, Esq., Staff Writer and Seth Whitelaw, Editor, for Life Science Compliance Update

The OIG’s recent Advisory Opinion suggest that under certain circumstances patient co-pay reimbursement programs are allowable. This article examines that opinion and highlights the types of controls that are likely needed.

Menu Title